SCHEMBL2867251

SCHEMBL2867251

COC(=O)c1ccc2[nH]nc(-c3nc4ccccc4s3)c2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 2/20 0.54
ILK Q13418 1/20 0.49
ALDH1A1 P00352 2/20 0.47
MAPT P10636 7/20 0.46
RAB9A P51151 3/20 0.46
NPC1 O15118 2/20 0.46
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
TSHR P16473 1/20 0.44
CRHBP P24387 1/20 0.44
CRHR2 Q13324 1/20 0.44
RXFP1 Q9HBX9 1/20 0.43
MAP2K4 P45985 2/20 0.42
KDM4E B2RXH2 2/20 0.42
POLB P06746 1/20 0.42
GLO1 Q04760 1/20 0.42
FLT1 P17948 1/20 0.42
MAPK1 P28482 1/20 0.42
TP53 P04637 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2859537 0.88 FGFR1 (0.53) FGFR1ILKMAPTRAB9ANPC1
SCHEMBL5377524 0.81 MAPK10 (0.53) FGFR1MAP2K4KDM4EFLT1MAPK1
SCHEMBL2866668 0.80 ALOX15 (0.44) FGFR1ALDH1A1RAB9ANPC1MAP2K4
SCHEMBL13198204 0.78 FLT3 (0.54) FGFR1ILKALDH1A1KDM4EMAPK1
SCHEMBL2863569 0.77 LRRK2 (0.56) MAP2K4KDM4EMAPK1FLT3
SCHEMBL2860104 0.77 PIM1 (0.53) FGFR1ALDH1A1RAB9ANPC1MAP2K4
SCHEMBL5379661 0.77 MAPK1 (0.46) MAPTRAB9ANPC1MAP2K4KDM4E
SCHEMBL2861069 0.76 ALPL (0.54) MEN1KMT2AMAP2K4KDM4EMAPK1
SCHEMBL2857271 0.76 MAPK1 (0.46) FGFR1MAP2K4KDM4EFLT1MAPK1
SCHEMBL16405025 0.75 ALDH1A1 (0.60) ALDH1A1MAPTRAB9ANPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
CN-1300116-C 1H-indazole compounds EISAI CO LTD (JP) 2007-02-14 CN disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
CN-1512987-A Novel 1H-indazole compound ������������ʽ���� 2004-07-14 CN disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed
EP-1380576-A1 NOVEL 1H-INDAZOLE COMPOUND Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 FGFR1 178/4885ILK 1031/4885ALDH1A1 1588/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 FGFR1 288/4885ILK 787/4885ALDH1A1 1744/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 FGFR1 178/4885ILK 1031/4885ALDH1A1 1588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.